Marked differences in GPs' diagnosis of pneumonia between Denmark and Spain: a cross-sectional study

Sarah Friis Christensen1, Lars Christian Jørgensen, Gloria Cordoba

  • 1Section of General Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Abstract

Insights

Diagnoses of pneumonia in lower respiratory tract infections (LRTI) varied significantly between Denmark and Spain. Differences in diagnostic criteria may contribute to antibiotic overprescribing, particularly in Denmark.

Area of Science:

  • General Practice
  • Infectious Diseases
  • Antibiotic Stewardship

Background:

  • Identifying appropriate antibiotic use for lower respiratory tract infections (LRTI) is challenging.
  • International guidelines differentiate treatment for pneumonia versus acute bronchitis.
  • Overdiagnosis of pneumonia can lead to unnecessary antibiotic prescribing.

Purpose of the Study:

  • Compare pneumonia prevalence in LRTI patients between Denmark and Spain, countries with differing antibiotic prescribing rates.
  • Identify key symptoms and clinical findings influencing general practitioners' (GPs) pneumonia diagnosis over acute bronchitis.

Main Methods:

  • Cross-sectional study within the EU-funded HAPPY AUDIT project.
  • Inclusion of 2,698 patients diagnosed with LRTI.
  • Data collected from GPs in Denmark and Spain.

Main Results:

  • Pneumonia prevalence in LRTI was 47% in Denmark versus 11% in Spain.
  • Spanish GPs prioritized fever and positive X-ray for pneumonia diagnosis.
  • Danish GPs placed greater importance on dyspnea/tachypnea and elevated C-reactive protein (>50mg/L).

Conclusions:

  • Significant differences exist in GPs' diagnostic criteria for pneumonia between Denmark and Spain.
  • High pneumonia prevalence in Danish LRTI patients suggests potential overdiagnosis.
  • This overdiagnosis may contribute to increased antibiotic prescribing rates.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
88
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
58
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K